$MANORAMA Manorama Industries Ltd has reported a stellar Q1 FY27

$MANORAMA Manorama Industries Ltd has reported a stellar Q1 FY27 performance with revenue surging 39.5% year‑on‑year to ₹4,040 million and profit after tax (PAT) jumping 67.6% to ₹786.6 million. The company also completed a ₹500 crore Qualified Institutional Placement (QIP) and announced a ₹460 crore capex plan for expansion. 📈 Financial Highlights (Q1 FY27) Metric Q1 FY27 Q1 FY26 Growth Revenue ₹4,040 million ₹2,895.5 million +39.5% EBITDA ₹1,062.1 million ₹747.3 million +42.2% EBITDA Margin 26.3% 25.8% +0.5 pp PAT ₹786.6 million ₹469.2 million +67.6% PAT Margin 19.5% 16.2% +3.3 pp Key drivers: Strong demand for value‑added specialty fats. Higher capacity utilization and improved product mix. Operational efficiency from upgraded fractionation and refinery units. 🏭 Strategic Developments ₹500 crore QIP completed (July 2026) to strengthen the balance sheet. ₹460 crore capex cycle planned over FY27–FY28 for expansion in fractionation, solvent extraction, and refinery capacities. New subsidiaries being incorporated in Chad and Burkina Faso, with operations ramping up in Brazil. Focus on West Africa and Latin America sourcing to secure raw materials and diversify supply chains. 💹 Stock Snapshot (as of 14 Aug 2026) Exchange Price Change Trend BSE ₹1,710.05 +₹94.90 (+5.88%) Bullish (long‑term) NSE ₹1,614.10 −₹11.90 (−0.73%) Neutral (short‑term) 52‑week range: ₹1,064.50 – ₹1,705.00 Technical outlook: Long‑term bullish; short‑term neutral to moderately bearish. Investors are advised to await confirmation of trend reversal before fresh entry. 🧾 Regulatory & Corporate Updates Clarification on delay in disclosure under SEBI (LODR) Reg. 30 (11 Aug 2026). Compliance certificate under SEBI (DP) Reg. 74 (5) for Q1 FY27 (10 Jul 2026). Incorporation of wholly owned subsidiary in Chad (9 Jul 2026). Allotment of 12,500 equity shares under ESOP scheme (3 Jul 2026). Closure of trading window (26 Jun 2026).